NJM Packaging, a ProMach product brand in the Pharma Business Line, is a trusted automated packaging systems manufacturer, integrator, and support resource.
NJM Packaging, a ProMach product brand in the Pharma Business Line, is a trusted automated packaging systems manufacturer, integrator, and support resource. We offer a broad range of technology, specializing in the needs of pharmaceutical, nutraceutical/ vitamin, and personal care product packagers. At NJM, we focus on delivering superior value to our customers by exceeding expectations with high-end equipment and the best service in the industry. These standards defined our young company 100 years ago, and we are proud to continue the tradition by constantly evolving and improving products and service offered to our customers.
NJM Packaging
5600 Kieran, Montreal, QC
800·811·6990
info@NJMPackaging.com
INTERPHEX Booth #2353
Transformations in Drug Development for Cell and Gene Therapies
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
The Role of Forced Degradation in Method Development, Manufacturability, and CMC Strategy
April 28th 2025Forced degradation studies are critical in biologics development, particularly for monoclonal antibodies (mAbs). These studies simulate long-term environmental stressors to uncover degradation pathways and ensure the stability of critical quality attributes (CQAs), aiding in robust chemistry, manufacturing, and controls (CMC) strategies and regulatory compliance.
Advancing Clinical Trials with Spectral Flow Cytometry: A Conversation with Kevin Lang
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.